John Engelhardt

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Dr. John Engelhardt is the director at the University of Iowa Center for Gene Therapy of Cystic Fibrosis, as well as the head of the department of anatomy and cell biology. He is known as the creator of the first cloned ferret, and for his work in finding a cure for cystic fibrosis.

Dr. John Engelhardt is the director at the University of Iowa Center for Gene Therapy of Cystic Fibrosis, as well as the head of the department of anatomy and cell biology. He is known as the creator of the first cloned ferret, and for his work in finding a cure for cystic fibrosis.

Education

Engelhardt got his undergraduate degree in biochemistry at Iowa State University in 1985. He then went on to get his doctorate in human genetics from Johns Hopkins University in 1990.

Research

Engelhardt is most widely known for his creation of new animal models for the study of cystic fibrosis. In the 1990s he developed the human tracheal xenograft models that allowed study of humanized airways on denuded rat tracheal scaffolds. However, he soon found that there were major limitation of mouse models to study CF. He later found that the ferret represents a much better model for lung disease, and in 2006 his laboratory became the first in the world to clone ferrets.

Engelhardt's research has been geared towards finding gene therapies for cystic fibrosis.

Specifically, he focuses on: the study of lung molecular and cellular biology as it relates to the pathogenesis and treatment of cystic fibrosis lung disease and associated diabetes molecular mechanisms underlying redox-mediated signal transduction in environmental injuries of the liver, and the development of molecular therapies for ischemia/reperfusion injury, sepsis, and the neurodegenerative disease amyotrophic lateral sclerosis (ALS) the biology of adeno-associated virus infection and the development of this vector for gene therapy of cystic fibrosis lung disease.

Honors

1999: Philip C. and Ethel F. Ashby Lecturer, University of Oklahoma 2003–2006: Elected to board of directors of the American Society of Gene Therapy 2004: Roy J. Carver Chair in Molecular Medicine 2005: NIH MERIT Award (NIDDK) 2011: University of Iowa Graduate College Outstanding Faculty Mentor Award: Biological and Life Sciences 2012: University of Iowa Graduate College Fall Commencement Address 2012: Liupan Mountain Friendship Award, Ningxia Foreign Experts Bureau, Ningxia, P.R.C. (Commends foreign experts for their contributions to Ningxia's economic construction) 2015: Regents Award for Faculty Excellence, University of Iowa 2019: Fellow of the National Academy of Inventors

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1319482621 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.